28 Tex. Admin. Code § 19.1820 - Prior Authorization Request Form for Prescription Drug Benefits, Required Acceptance, and Use
(a) Form requirements.
The commissioner adopts by reference the Prior Authorization Request Form for
Prescription Drug Benefits form, to be accepted and used by an issuer in
compliance with subsection (b) of this section. The form and its instruction
sheet are on TDI's website at www.tdi.texas.gov/forms/form10.html;
or the form and its instruction sheet can be requested by mail from the Texas
Department of Insurance, Rate and Form Review Office, MC: LH-MCQA, PO Box
12030, Austin, Texas 78711-2030. The form must be reproduced without changes.
The form provides space for the following information:
(1) the name of the issuer or the issuer's
agent that manages prescription drug benefits, telephone number, and fax
number;
(2) the date the request is
submitted;
(3) a place to request
an expedited or urgent review if the prescribing provider or the prescribing
provider's designee certifies that applying the standard review time frame may
seriously jeopardize the life or health of the patient or the patient's ability
to regain maximum function;
(4) the
patient's name, contact telephone number, date of birth, sex, address, and
identifying insurance information;
(5) the prescribing provider's name, NPI
number, specialty, telephone and fax numbers, address, and contact person's
name and telephone number;
(6) for
a prescription drug:
(A) drug name;
(B) strength;
(C) route of administration;
(D) quantity;
(E) number of days' supply;
(F) expected therapy duration; and
(G) to the best of the prescribing provider's
knowledge, whether the medication is:
(i) a
new therapy; or
(ii) continuation
of therapy, and if so, to the best of the prescribing provider's knowledge:
(I) the approximate date therapy was
initiated;
(II) whether the patient
is adhering to the drug therapy regimen; and
(III) whether the drug therapy regimen is
effective;
(7) for a provider administered drug, the
HCPCS code, NDC number, and dose per administration;
(8) for a prescription compound drug, its
name, ingredients, and each ingredient's NDC number and quantity;
(9) for a prescription device, its name,
expected duration of use, and, if applicable, its HCPCS code;
(10) the patient's clinical information,
including:
(A) diagnosis, ICD version number
(if more than one version is allowed by the U.S. Department of Health and Human
Services), and ICD code;
(B) to the
best of the prescribing provider's knowledge, the drugs the patient has taken
for this diagnosis, including:
(i) drug name,
strength, and frequency;
(ii) the
approximate dates or duration the drugs were taken; and
(iii) patient's response, reason for failure,
or allergic reaction;
(C)
the patient's drug allergies, if any; and
(D) the patient's height and weight, if
relevant;
(11) a list of
relevant lab tests, and their dates and values;
(12) a place for the prescribing provider to:
(A) include pertinent clinical information to
justify requests for initial or ongoing therapy, or increases in current
dosage, strength, or frequency;
(B)
explain any comorbid conditions and contraindications for formulary drugs;
or
(C) provide details regarding
titration regimen or oncology staging, if applicable; and
(13) a directive to the prescribing provider
stating that:
(A) for a request for prior
authorization of continuation of therapy (other than a request for a
step-therapy exception as provided in subparagraph (B) of this paragraph), it
is not necessary to complete the sections of the form regarding patient
clinical information and justification for the therapy unless there has been a
material change in the information previously provided; and
(B) for a request for a step-therapy
exception, the section of the form regarding justification for the step-therapy
exception must be completed.
(b) Acceptance and use of the form.
(1) If a prescribing provider submits the
form to request prior authorization of a prescription drug benefit for which
the issuer's plan requires prior authorization, the issuer must accept and use
the form for that purpose. An issuer may also have on its website another
electronic process a prescribing provider may use to request prior
authorization of a prescription drug benefit.
(2) This form may be used by a prescribing
provider to request prior authorization of:
(A) a prescription drug;
(B) a prescription device;
(C) formulary exceptions;
(D) quantity limit overrides; and
(E) step-therapy requirement
exceptions.
(3) This form
may not be used by a prescribing provider to:
(A) request an appeal;
(B) confirm eligibility;
(C) verify coverage;
(D) ask whether a prescription drug or device
requires prior authorization; or
(E) request prior authorization of a health
care service.
(c) Effective date. An issuer must accept a
request for prior authorization of prescription drug benefits made by a
prescribing provider using the form on or after the effective date of this
section. An issuer must accept a request using the form that was in place prior
to the effective date of this section for 90 days after the effective
date.
(d) Availability of the form.
(1) A health benefit plan issuer must make
the form available electronically on its website.
(2) A health benefit plan issuer's agent that
manages or administers prescription drug benefits must make the form available
electronically on its website.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.